calcitriol (Rocaltrol) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:


Excessive vitamin D may lead to hypercalcemia (abnormally high levels of calcium in the blood), hypercalciuria (elevated levels of calcium in the urine), hyperphosphatemia (high levels of phosphate in the blood), and bone disease. To avoid complications, vitamin D and its derivatives should be avoided during calcitriol therapy.

Hypercalcemia has been reported in patients treated with calcitriol. Patients should avoid making any sudden changes in their dietary calcium intake and maintain adequate intake of fluid (hydration) during treatment.




  • Oral liquid filled capsules: 0.25 and 0.5 mcg
  • Oral solution: 1 mcg/ml
  • Solution for injection: 1 and 2 mcg/ml

STORAGE: Calcitriol should be stored at room temperature, between 15 C and 30 C (59 F and 86 F). Protect from light.


  • The recommended initial oral dose for treating low calcium due to kidney dialysis is 0.25 mcg daily.
  • The dose may be increased by 0.25 mcg daily every 4 to 8 weeks.
  • Most patients respond to 0.5 to 1 mcg daily.
  • The oral dose for treating hypoparathyroidism is 0.25 mcg to 2 mcg daily.
Medically Reviewed by a Doctor on 10/7/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index